Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Iwakaji A"'
Publikováno v:
Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 327-338 (2016)
Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics,
Externí odkaz:
https://doaj.org/article/eba0ec9c8a7446ddad6aac56dcd05e56
Autor:
Tatsunori Sakano, Kento Adachi, Tomoaki Inokuchi, Kazuto Takao, Yoko Iwakaji, Ryohei Gejo, Tomoko Matsudai
Publikováno v:
2022 IEEE 34th International Symposium on Power Semiconductor Devices and ICs (ISPSD).
Publikováno v:
In Nuclear Inst. and Methods in Physics Research, A 1-21 September 2010 621(1-3):650-655
Publikováno v:
2021 33rd International Symposium on Power Semiconductor Devices and ICs (ISPSD).
A triple-gate 1.2-kV Si-insulated-gate bipolar transistor (TG-IGBT) is proposed in order to drastically improve both turn-on loss (Eon) and turn-off loss (Eoff) by using a novel gate drive control technique. In this work, we fabricated a 1.2-kV TG-IG
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Applied Surface Science 2008 254(19):6277-6280
Publikováno v:
Extended Abstracts of the 2020 International Conference on Solid State Devices and Materials.
Publikováno v:
Japanese Journal of Applied Physics. 60:SBBD02
The double-gate drive is a remarkable gate control technique for dramatically reducing turn-off loss in Si-insulated gate bipolar transistors (IGBT) by increasing dV CE/dt. However, no detailed analysis of the difference of turn-off mechanism accordi
Publikováno v:
Japanese Journal of Applied Physics; 5/15/2021, Vol. 60 Issue SB, p1-9, 9p
Autor:
Tadakatsu Nakamura, Atsushi Iwakaji, Masayoshi Imada, Tomoko Kubota, Yasunori Morio, Margit Kapás
Publikováno v:
Drug Design, Development and Therapy
Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics,